Aerobiology
Contact
(409) 266-6933
(409) 392-0042
The function of the Aerobiology Services Division is to off er state-of-the art facilities for aerosol science and inhalational exposure to support researchers who would like to develop, test or evaluate therapeutics/vaccines against aerosolized infectious agents either at BSL-3 or BSL-4.
The Aerobiology Services Division focuses on testing therapeutics against a variety of biological agents. The trained staff has expertise in the operation of the aerosol equipment and knowledge of infectious disease agents that enables them to work safely with other trained personnel on any infectious agent considered a biothreat. The Division is developing the capability to test drugs, vaccines and diagnostics in compliance with FDA’s Good Laboratory Practices (GLP) guidelines. The division operates as a service center and as such has completed 15+ aerosol exposures over the past year in ABSL-3 and BSL-4 aerobiology suites.
Capabilities
- Animal model development for various infectious agents
- Drug efficacy studies
- Immunogenicity testing
- LD50 determinations
- Vaccine efficacy testing
- Quality control testing
- Regulatory support for FDA
- Submissions
Services for studies initiated in facility
- Fully trained personnel
- Standardized SOPs
- Forms and checklist documentation that is quality controlled and approved deviation reporting
- Data security
- Equipment qualification, preventative maintenance, calibration and performance verification
- Protocol approval
- Interim and final reporting
- Document control
- Environmental monitoring